Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide crossover study of osteocalcin, testosterone, and insulin sensitivity in men with primary osteoporosis
NL-OMON27144Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of teriparatide in involutional osteoporosis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Undercarboxylated osteocalcin, Testosterone concentrations and 2 more. Started Feb 2013; status: active, not recruiting.
02
Drugs
teriparatide
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on NL-OMON27144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27144.